BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 1,500,000 shares, a decrease of 6.3% from the February 28th total of 1,600,000 shares. Approximately 14.6% of the company’s stock are short sold. Based on an average […]